Volume 23, Number 1—January 2017
Research
Sequelae and Other Conditions in Ebola Virus Disease Survivors, Sierra Leone, 2015
Figure 1

Figure 1. Hospital discharge and attendances for 115 survivors of laboratory-confirmed Ebola virus disease (EVD) attending the Survivor Clinic at Kenema Government Hospital (KGH), Kenema, Sierra Leone), 2014–2015. A) Discharge from KGH after initial EVD diagnosis for the 88 (76.5%) survivors for whom data were available on date of EVD discharge. B) Dates of the 621 attendances at KGH during convalescence by the 115 EVD survivors.
Page created: December 14, 2016
Page updated: December 14, 2016
Page reviewed: December 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.